Physician profile
David Barba
NPI 1093730251
$8,090.84
in general payments reported to CMS, 2019-2025
18 companies · $3,100 in 2025
The $3,100 reported for 2025 was more than what 75% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $990 · 2020: $283 · 2021: $231 · 2022: $33.73 · 2023: $2,534 · 2024: $920 · 2025: $3,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,400 · Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,400.00 |
| Food and Beverage | $153.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clearpoint Neuro, INC. | $6,400.00 | 2023-2025 | Clearpoint |
| Ge Healthcare | $322.68 | 2019-2020 | |
| Boston Scientific Corporation | $251.06 | 2019-2021 | |
| Abbott Laboratories | $241.44 | 2019 | |
| Medtronic, INC. | $168.09 | 2022-2023 | Percept Pc Brainsense |
| Astrazeneca Pharmaceuticals Lp | $113.39 | 2021 | |
| Merz North America, INC. | $100.00 | 2019 | |
| Medtronic Vascular, INC. | $88.54 | 2019 | |
| Medtronic USA, INC. | $80.55 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $74.39 | 2019-2020 | |
| Pfizer INC. | $50.63 | 2020 | |
| Lundbeck LLC | $45.31 | 2019 | |
| Adamas Pharmaceuticals, INC. | $35.42 | 2019-2020 | |
| Abbvie INC. | $32.67 | 2019 | |
| Neurocrine Biosciences, INC. | $26.73 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $21.51 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.57 | 2024 | Jardiance |
| Genzyme Corporation | $18.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Barba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.